Jones Trading Starts Decibel Therapeutics Inc (DBTX) at Buy
- Wall St eyes subdued open after selloff on Fed worries
- BofA says S&P 500 could drop to 3000 in H123
- Deutsche Bank goes against consensus, sees S&P 500 rallying to 4500
- Positioning suggests 'limited' investor conviction behind recent rally - Citi
- GitLab (GTLB) surges 20% on better-than-feared results, analysts positive
Jones Trading initiates coverage on Decibel Therapeutics Inc (NASDAQ: DBTX) with a Buy rating and a price target of $25.00.
Shares of Decibel Therapeutics Inc closed at $6.77 yesterday.
You May Also Be Interested In
- Jefferies Starts RXO, Inc. (RXO) at Buy; Trading at Discount to Peers
- UBS Starts United Therapeutics Corp. (UTHR) at Buy; 'Tyvaso diversified growth ahead'
- Barclays Reinstates Ipsen SA (IPN:FP) (IPSEF) at Equalweight
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!